Novavax Stock Looks Like a Good Value With Its New Combined Vaccine

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

NVAX stock could be worth 63% more based on its new combination flu and Covid-19 vaccine after passing Phase 1/2 clinical trials.

The post Novavax Stock Looks Like a Good Value With Its New Combined Vaccine appeared first on InvestorPlace.

• Stock Prodigy Who Found NIO at $2… Says Buy THIS
• It doesn’t matter if you have $500 in savings or $5 million. Do this now.
• Get in Now on Tiny $3 ‘Forever Battery’ Stock
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”